Medpace Holdings (FRA:01P) Total Liabilities : €1,034 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Total Liabilities?

Medpace Holdings's Total Liabilities for the quarter that ended in Mar. 2024 was €1,034 Mil.

Medpace Holdings's quarterly Total Liabilities increased from Sep. 2023 (€951.81 Mil) to Dec. 2023 (€1,006.75 Mil) and increased from Dec. 2023 (€1,006.75 Mil) to Mar. 2024 (€1,034.31 Mil).

Medpace Holdings's annual Total Liabilities increased from Dec. 2021 (€625.70 Mil) to Dec. 2022 (€912.01 Mil) and increased from Dec. 2022 (€912.01 Mil) to Dec. 2023 (€1,006.75 Mil).

Medpace Holdings Total Liabilities Historical Data

The historical data trend for Medpace Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Total Liabilities Chart

Medpace Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

375.11

480.79

625.70

912.01

1,006.75

Medpace Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															979.26	937.66	951.81	1,006.75	1,034.31

Medpace Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Medpace Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	848.345	+	(130.326	+	25.879
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	2.204	+	0)
	=	1,007

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1519.311	-	512.557
	=	1,007

Medpace Holdings's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	880.113	+	(125.264	+	26.755
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	2.175	+	0)
	=	1,034

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1652.126	-	617.819
	=	1,034

Medpace Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings (FRA:01P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MEDP:USA MEDP:Mexico 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Medpace Holdings (FRA:01P) Headlines

No Headlines